drugset / Trial / NCT01335867
Vigabatrin for Cocaine and Alcohol Dependence
Phase 2
Terminated
32 enrolled
University of Pennsylvania
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the effectiveness of vigabatrin at reducing drug and alcohol use in individuals addicted to cocaine and alcohol. Vigabatrin is approved for the treatment of seizures. It has not been proven to be effective for the treatment of alcohol or cocaine dependence.
Timeline
- Start
- 2011-04
- Primary completion
- 2013-04
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vigabatrin | Small molecule | 3 g | — |